Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
August 10, 2022

FDA grants EUA for Bavarian Nordic’s Jynneos vaccine for monkeypox

Bavarian Nordic’s vaccine, Jynneos, has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) to increase vaccine supply for monkeypox.

Bavarian Nordic’s Jynneos is the only FDA-approved vaccine for the prevention of monkeypox virus. Credit: Bavarian Nordic.